Glioblastoma News and Research

RSS
Glioblastoma is the most aggressive and malignant form of glioma, a type of primary brain cancer. Surgery is often used to treat gliomas, along with radiation. However, since surgery and radiation fail to cure the disease, doctors may turn to additional radiation or chemotherapy. In early stages glioblastoma tumors often grow without symptoms and therefore can become quite large before symptoms arise. When the tumor becomes symptomatic, tumor growth is usually very rapid and is accompanied by altered brain function, and if left untreated the disease becomes lethal. Although primary treatment is often successful in temporarily stopping the progression of the tumor, glioblastomas almost always recur and become lethal.
Getting the Most Out of the CLARITY Technique

Getting the Most Out of the CLARITY Technique

The EORTC Brain Tumor Group and Protagen AG collaborate to study immuno-competence of long-term glioblastoma survivors

The EORTC Brain Tumor Group and Protagen AG collaborate to study immuno-competence of long-term glioblastoma survivors

Scientists find answers to how cancer spreads

Scientists find answers to how cancer spreads

UA researchers discover promising lead in genetic approach to treating deadly brain cancer

UA researchers discover promising lead in genetic approach to treating deadly brain cancer

Merck declares 2018 Life Science Award winners

Merck declares 2018 Life Science Award winners

New solution to stop spread of brain cancer

New solution to stop spread of brain cancer

Scientists solve 125-year-old mystery of the brain, uncover potential treatment for epilepsy

Scientists solve 125-year-old mystery of the brain, uncover potential treatment for epilepsy

Researchers find new tiny molecule that is capable of killing medulloblastoma

Researchers find new tiny molecule that is capable of killing medulloblastoma

Promising new glioblastoma treatment could improve and extend patients' lives

Promising new glioblastoma treatment could improve and extend patients' lives

Special chemical that makes brain tumours glow pink to help neurosurgeons operate

Special chemical that makes brain tumours glow pink to help neurosurgeons operate

Celprogen successfully prints 3D Brains from brain stem cells to study neurological disease stages

Celprogen successfully prints 3D Brains from brain stem cells to study neurological disease stages

New ddPCR technology helps detect, quantify TERT promoter mutations linked to many cancer types

New ddPCR technology helps detect, quantify TERT promoter mutations linked to many cancer types

New Penn Medicine Center offers hope in the fight against glioblastoma

New Penn Medicine Center offers hope in the fight against glioblastoma

New City of Hope CAR T cell trial focuses on HER2-positive breast cancer patients with brain metastases

New City of Hope CAR T cell trial focuses on HER2-positive breast cancer patients with brain metastases

Deciphera presents Phase 1 clinical results of DCC-2618 in patients with gastrointestinal stromal tumors

Deciphera presents Phase 1 clinical results of DCC-2618 in patients with gastrointestinal stromal tumors

Notable improvement in brain cancer survival among younger patients but not much for elderly

Notable improvement in brain cancer survival among younger patients but not much for elderly

New blood test for pediatric brain tumor patients offers safer approach than surgical biopsies

New blood test for pediatric brain tumor patients offers safer approach than surgical biopsies

TEAD1 protein appears to be important regulator of tumor migration in glioblastoma

TEAD1 protein appears to be important regulator of tumor migration in glioblastoma

First-in-human phase 0 study shows clinically-relevant activity of new drug in glioblastoma

First-in-human phase 0 study shows clinically-relevant activity of new drug in glioblastoma

Zika virus could become a weapon against brain cancer

Zika virus could become a weapon against brain cancer